CTGT
HNL Genomics (formerly CTGT / Connective Tissue Gene Tests) is the clinical genomics division of HNL Lab Medicine, providing molecular diagnostic testing in inherited genetics, cytogenetics, and molecular oncology, prenatal, and cardiology for physicians, genetic counselors, hospitals, and patients across the Lehigh Valley region.
- Company typePrivate
- Founded2004
- HeadquartersAllentown, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CTGT does
HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is the clinical genomics division of HNL Lab Medicine, a private regional clinical laboratory headquartered in the Lehigh Valley of Pennsylvania with over 50 patient service center locations. The division provides molecular diagnostic testing across three operating units — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — covering oncology, prenatal (including non-invasive prenatal screening), cardiology, and inherited genetic disorders. Its test portfolio supports physicians, genetic counselors, hospitals, health systems, and clinics in the Lehigh Valley region and into New York State.
The underlying technology stack combines Next Generation Sequencing (NGS) for variant-level analysis, chromosome microarray for high-resolution copy-number detection, fluorescence in situ hybridization (FISH) for targeted cytogenetic interrogation, and the MetaSystems platform for automated karyotyping and FISH image analysis. The lab holds CAP accreditation and references additional licensure, certifications, and accreditation documentation, supporting contracting with institutional providers and out-of-state referral work. Distribution runs through a regional patient service center network, a provider portal for direct physician ordering, courier specimen pickup for healthcare facilities, and HNL @Home for homebound patients.
Revenue is generated through fee-for-service clinical laboratory testing billed to healthcare providers, insurance payors, and patients. The go-to-market is a B2B enterprise field sales motion targeting physicians, genetic counselors, and institutional accounts, supplemented by direct-to-consumer test ordering. Pricing is not publicly disclosed; inquiries are routed through a genomics phone line and dedicated email channel.
CTGT firmographics
Firmographics- Name
- CTGT
- Legal name
- HNL Lab Medicine
- Website
- https://ctgt.net
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HNL Genomics (formerly CTGT / Connective Tissue Gene Tests) is the clinical genomics division of HNL Lab Medicine, providing molecular diagnostic testing in inherited genetics, cytogenetics, and molecular oncology, prenatal, and cardiology for physicians, genetic counselors, hospitals, and patients across the Lehigh Valley region.
- Ownership category
- akta.pro rank
CTGT industry classification
Industry- Product category
- Clinical Genetic Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industries
- Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
Keywords
Where CTGT is headquartered
LocationHeadquarters
- HQ city
- Allentown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CTGT business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Laboratory Genetic Testing Services: HNL Genomics provides genetic testing services to healthcare providers and patients, operating as a diagnostic laboratory within HNL Lab Medicine. Revenue is generated through laboratory testing services billed to healthcare providers, insurance companies, and patients. Services span three divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics covering oncology, prenatal, and cardiology specialties.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
CTGT product offering
Product offeringCore offering
HNL Genomics (formerly Connective Tissue Gene Tests / CTGT) is a clinical laboratory that performs molecular diagnostic and cytogenetic testing for inherited genetic disorders, cancer, prenatal indications, and cardiology. Testing is delivered across three divisions — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — using Next Generation Sequencing, chromosome microarray, FISH, and MetaSystems-based karyotyping to support physician diagnosis, prognosis, recurrence-risk assessment, and targeted therapy selection.
Product overview
HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is a genetic testing services provider organized into three integrated divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics. These divisions work together to provide comprehensive genomic testing across specialties including Oncology, Prenatal, Cardiology, and Inherited Genetics, offering diagnostic results that aid in the development of specialized treatment plans for patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Inherited Genetics Division Testing Services
Companies that use CTGT
Customer profileSegments3 records
Ideal customer profiles1 record
CTGT technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CTGT partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MetaSystemscoreHNL Genomics utilizes MetaSystems technology for automated karyotyping and fluorescence in situ hybridization (FISH) analysis in their cytogenetics laboratory. MetaSystems provides advanced imaging and analysis platforms for chromosome analysis supporting the diagnosis, prognosis, and monitoring of oncologic malignancies.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
CTGT competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: National clinical reference laboratory with an extensive genetic and molecular diagnostics menu (including Quest's own NIPS and hereditary cancer offerings). Competes with HNL Genomics across all three divisions, but as a broad-line incumbent rather than a genomics specialist.
- ARUP Laboratories: National reference laboratory affiliated with the University of Utah offering esoteric genetic, molecular, and cytogenetic testing. Comparable to HNL Genomics' reference/esoteric positioning, especially in cytogenetics and inherited disorders.
- Labcorp: National reference lab offering integrated clinical and genetic/molecular diagnostic services including NIPS, oncology, and inherited disorder panels. Comparable on test menu and payer relationships, with substantially broader geographic reach.
Direct peers
- Natera: Specialized molecular diagnostics company with strong prenatal (NIPS), oncology, and transplant testing offerings. Directly comparable to HNL Genomics' prenatal screening and molecular oncology divisions on technology and clinician customers.
- Integrated Genetics (Labcorp Specialty Testing): Labcorp specialty genetics lab offering reproductive and prenatal genetic testing including NIPS and carrier screening. Directly comparable to HNL Genomics' prenatal screening division on test type and clinician customer.
- GeneDx: Clinical genomics lab specializing in rare disease and pediatric hereditary testing using exome and genome sequencing. Comparable to HNL Genomics' inherited genetics division in target clinicians and test methodology.
- Invitae: Genetic testing company offering hereditary cancer, reproductive health, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics divisions in test menu and clinical customer base.
- Ambry Genetics: Clinical genetic testing lab (now part of Konica Minolta) offering hereditary cancer, reproductive, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics offerings.
- Myriad Genetics: Established genetic testing lab focused on hereditary cancer, prenatal, and pharmacogenomics. Comparable to HNL Genomics on specialty genetic testing menu and clinician-driven GTM motion.
- PreventionGenetics: Clinical DNA testing laboratory (part of Exact Sciences) offering hereditary cancer, cardiac, and rare disease genetic testing. Comparable on multi-specialty genetic test menu and clinician ordering workflow.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks4 records
Key highlights5 records
Customer concentration
CTGT social profiles
Digital presenceCTGT compliance and trust
Trust signalCompliance1 record
CTGT financial estimates
Financial estimateRevenue estimate
Valuation estimate
CTGT leadership team
Management profileNumber of profiles
CTGT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CTGT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CTGT
What does CTGT do?
HNL Genomics (formerly Connective Tissue Gene Tests / CTGT) is a clinical laboratory that performs molecular diagnostic and cytogenetic testing for inherited genetic disorders, cancer, prenatal indications, and cardiology. Testing is delivered across three divisions — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — using Next Generation Sequencing, chromosome microarray, FISH, and MetaSystems-based karyotyping to support physician diagnosis, prognosis, recurrence-risk assessment, and targeted therapy selection.
Is CTGT a public or private company?
CTGT is a private company. It is classified as corporate owned and is currently operating.
When was CTGT founded?
CTGT was founded in 2004. It employs 11 to 50 people.
Where is CTGT based?
CTGT is headquartered in Allentown, United States, in the North America region.
How does CTGT make money?
One revenue line is on record: clinical Laboratory Genetic Testing Services.
Who are CTGT's main competitors?
Broad incumbents on record are Quest Diagnostics, ARUP Laboratories and Labcorp. Direct peers are Natera, Integrated Genetics (Labcorp Specialty Testing), GeneDx, Invitae, Ambry Genetics, Myriad Genetics and PreventionGenetics.
Does CTGT have an API?
No public API is recorded for CTGT.
What industry is CTGT in?
CTGT's product category is Clinical Genetic Testing Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.